PharmAla Biotech
C$0.08
22
+C$0+0% Friday 19:59
统计数据
当日最高
0.08
当日最低
0.07
52周最高
0.35
52周最低
0.07
成交量
106,861
平均成交量
252,870
市值
16.18M
市盈率
-
股息收益率
-
股息
-
收益
31May预期
预期每股收益
N/A
实际每股收益
-0.0025
人们还关注
此列表基于关注MDMA.CN的Stock Events用户的观察列表。这不是投资建议。
竞争者
这个列表是基于最近市场事件的分析。这不是投资建议。
Compass Pathways
CMPS
市值511.54M
Mind Medicine
MNMD
市值493.47M
GH Research
GHRS
市值546.3M
ATAI Life Sciences N.V.
ATAI
市值218.14M
Cybin
CYBN
市值194.47M
Revive Therapeutics
RVVTF
市值3.99M
关于
Pharmala Biotech Holdings Inc., doing business as PharmAla, focuses on the developing, manufacturing, and commercializing of substituted methylenedioxy-phenethylamines (MDXX) active pharmaceutical ingredients. It also provides MDXX class compounds, such as 1,3-Benzodioxolyl-Nmethylbutanamine (MBDB); and 3,4-Methylenedioxy-N-ethylamphetamine (MDEA/MDE), as well as formulations of MDXX compounds. The company is headquartered in Vancouver, Canada.
Show more...
首席执行官
Mr. Nicholas Kadysh
国家
CA
ISIN
CA71719L1067